CDC Website CDC Website

To Join the NPIN community or

Home » AIDS Drug Assistance Program (ADAP) Emergency Relief Fund (ERF) » AIDS Drug Assistance Program (ADAP) Emergency Relief Fund (ERF)

Due to the evolving COVID-19 situation, NPIN may not have the most up-to-date organization changes to services or hours. Please call the organization or visit their website to find out about any changes. This site does not have information about where to get tested for COVID-19. For COVID-19 information please visit: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/testing.html

Debido a la rápida evolución de la situación con respecto al COVID-19, NPIN podría no tener la información mas actualizada de los servicios u horas de las organizaciones. Por favor llame o visite la página web de la organización para conocer los cambios. Este sitio no tiene información sobre donde hacerse la prueba del COVID-19. Para información sobre el COVID-19 por favor visite: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/testing.html

AIDS Drug Assistance Program (ADAP) Emergency Relief Fund (ERF)

This notice announces the opportunity to apply for funding under the Ryan White HIV/AIDS Program (RWHAP) Part B AIDS Drug Assistance Program (ADAP) Emergency Relief Funds (ERF). The Health Resources and Services Administration (HRSA), HIV/AIDS Bureau (HAB), Division of State HIV/AIDS Programs (DSHAP) administers this program. ADAP ERF awards are intended for states/territories that demonstrate the need for additional resources to prevent, reduce, or eliminate ADAP waiting lists, including through cost-containment measures (for example, the provision of health insurance assistance). HRSA will base ADAP ERF awards upon applicants’ ability to successfully demonstrate need for additional funding. An external objective review committee (ORC) will evaluate this need based on criteria published in this notice of funding opportunity (NOFO), with priority given to addressing existing waiting lists. HRSA first funded the ERF initiative in August 2010, when numerous states/territories were experiencing ADAP waiting lists. At the time of this NOFO publication, there are no ADAP waiting lists. States/territories that established a waiting list since the publication of this NOFO must report the waiting list to HRSA immediately and use funding awarded under this NOFO to remove clients from the waiting list. Previously, eligibility for this funding was limited to states/territories that had historically imposed waiting lists. This year, HRSA expects additional state/territory impact on ADAPs due to the economic downturn, resulting in more potential clients in need of ADAP services due to client loss of income and/or client loss of health care coverage. States/territories may use ERF funds to address current or projected increases in treatment needs aligned with ending the HIV epidemic or other unanticipated increases in the number of clients in the program. Applicants are encouraged to consider how their proposed activities with the ADAP ERF funding support HRSA’s emphasis on innovation, collaboration, impact, and effectiveness.

Funding Category
Support Types
Locations
National
Eligible Organizations
Number of Awards Given
30 awards.

Maximum Amount: 

75000000.00
Application Due Date
10/26/20
Project Start Date
4/1/21
Application Contact
Patryce
Peden
Grants Management Specialist
5600 Fishers Lane, Mailstop 10SWH03
Rockville
20857
United States
MD
301-443-2277
PPeden@hrsa.gov
Technical Contact
Susan
Robilotto, D.O.
Director, Division of State HIV/AIDS Programs
5600 Fishers Lane, Room 09W52
Rockville
20857
MD
SRobilotto@hrsa.gov
United States
301-443-6554
Fund Duration
One year.
Subjects
Audiences

Fund Number: 

348225

Fund ID: 

HRSA-21-057

Last modified: 

7/28/20